Pfizer’s Debt Concerns Cast Doubt on Viking Therapeutics Acquisition
Pfizer's interest in the weight loss market is uncertain due to its significant debt of over $70 billion and recent ...
- Latest
- Trending
Pfizer's interest in the weight loss market is uncertain due to its significant debt of over $70 billion and recent ...
Investors seeking a blend of growth, income, and value should consider Viking, Brookfield Renewable, and UPS. While UPS faced a ...
The U.S. lacks AI regulations, but is making progress in implementing safeguards. The Biden Administration introduced new guidance measures for ...
Delve into a comprehensive financial analysis of Cabaletta Bio Inc, a key player in the NASDAQ exchange, with a strong ...
Amazon Pharmacy is leveraging AI for its same-day delivery service expansion in New York City and Los Angeles. AI helps ...
Stay updated on the latest in biotech with our newsletter and podcast. Boundless becomes the ninth biotech company to go ...
The article discusses the declining American Dream and how people are increasingly seeking better opportunities outside the United States. This ...
Precision oncology company Boundless Bio is set to go public with a $100 million IPO on the Nasdaq, trading under ...
Moleculin Biotech's stock has been given a "sell" rating by a firm, with a 1-year low of $4.34 and a ...
Atticus Wealth Management LLC buys stake in Moleculin Biotech as the firm sets a “sell” rating on the stock; MBRX ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.